Genomic and epigenomic integration identifies a prognostic signature in colon cancer
about
Epigenetics Offer New Horizons for Colorectal Cancer PreventionDifferential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasionA decade of exploring the cancer epigenome - biological and translational implicationsEpigenetic therapy in gastrointestinal cancer: the right combinationTargeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilusEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerA novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLCWhole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphomaCombination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.Novel methylation biomarker panel for the early detection of pancreatic cancer.Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing.An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphomaEpigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.Filamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cellsEpigenetic alterations in inflammatory bowel disease and cancerPrognostic significance of aberrant gene methylation in gastric cancer.Towards universal screening for colon cancer: a cheap, reliable, noninvasive test using gene expression analysis of rectal swabs.Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer.CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis.Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.DNA methylation biomarker candidates for early detection of colon cancer.NCBI2RDF: enabling full RDF-based access to NCBI databasesConserved genes and pathways in primary human fibroblast strains undergoing replicative and radiation induced senescence.A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative ColitisDiagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.PROGgene: gene expression based survival analysis web application for multiple cancers.Toward a comprehensive and systematic methylome signature in colorectal cancers.CLINICAL EVALUATION OF AN EPIGENETIC ASSAY TO PREDICT MISSED CANCER IN PROSTATE BIOPSY SPECIMENS.Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancerAdvances in epigenetic biomarker research in colorectal cancerThe epigenetic promise for prostate cancer diagnosis.Epigenetics of colorectal cancer.Promoter CpG island methylation markers in colorectal cancer: the road ahead.Epigenetic biomarkers: potential applications in gastrointestinal cancersThe role of epigenetics in colorectal cancer.Clinical significance of epithelial-mesenchymal transition.DNA Methylation and Colorectal Cancer
P2860
Q22252606-7ED300E8-68C0-42D2-A3BD-9000DD232C8BQ24303907-B620FDF2-3C16-42BF-9DEF-694298F91EACQ24614467-E0394FD4-6BD8-4203-847F-758F0D2C065FQ26745709-945C0085-D945-435D-B085-4DA645A60980Q27027266-246AFD5A-40C8-4349-97E5-51B52377A52EQ28087759-7ABFC0B4-9D21-44F2-A727-9391BA58F72BQ28387995-F6D94355-643E-41E1-832E-1567C45BFCD6Q28537689-A9293D16-9720-4C20-8AC0-B1CC19A5331BQ33798842-871B626E-2787-4F04-BA50-37875AAC29C1Q34050656-9140BA3B-081C-4CFE-A987-3EA6BDF260B9Q34374959-018E6EBE-9F12-41D6-8FEF-92978C36EE7CQ34384230-F028D7AB-3D2F-43AC-AAC7-8A631F5D47D5Q34427855-2708CC3A-B543-4375-A01C-D7900C4B1A6AQ34487177-85ABA035-79E8-4D5A-A9AC-7AC4973DD07BQ34494956-70C10215-A253-4382-91BC-76D38FE39A42Q35176043-680F8AE4-BD97-4A4F-BD57-FC49A0ACB1B5Q35554170-4D9B32AD-C097-44B5-8ABF-B421A685A8DAQ35609447-3ADA7A3E-CFF6-4236-8D53-4878DE3B86C5Q35825551-7977DC30-FB6D-44C5-B26B-772AEF413172Q36025711-6D20D2EA-9CC6-44C8-BC0A-5E55C222A5ACQ36212916-B23960F7-E038-44D0-A218-A2C1FBB81999Q36351328-CCB0C1E5-D774-4C3A-AFFB-800086AC106AQ36407481-62D9A147-6997-412A-883B-5592062BA820Q36672397-88DEF88A-5F9B-4510-B2D3-B299A1D4A506Q37101218-2111AD55-2C54-4F88-8F47-70E14FBF2986Q37133206-B0F715F2-78A1-40AE-998A-D9620B004D87Q37210074-D5FA5069-1979-437D-975F-6A4BABC554DBQ37296090-48B28862-3572-480A-9E85-B3E51AC65FB5Q37420447-7873282C-3CC8-4855-B3F0-C67C6DF99639Q37445275-4848A8B9-6EE1-401A-AE94-3AC846A9AFC2Q37563750-991E3059-B06C-4959-83A4-1B0D65B1CFEEQ37578728-21324ACE-FE5C-42BA-858F-65202867CE81Q37708022-6D9BBF9D-8371-4172-AA53-558CBA9B5303Q37967574-E5793937-B86C-4930-8C47-3851E4070EC8Q37977477-348AE4C1-1A30-42BF-8507-AF0469E331F8Q37997086-46220399-470F-4AD5-ABD4-FC2FB813AC2CQ38204377-888864F4-B109-4381-A117-216AB9EDD498Q38215665-0C8A7D00-44F3-4AB7-A9BD-EE1899B0F38AQ38232585-BE9F7ABB-CE8E-417B-84AC-B6D0437BC0ECQ38314840-E893FC7B-446A-44B9-8C60-09DCF96D96A2
P2860
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@ast
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@en
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@nl
type
label
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@ast
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@en
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@nl
prefLabel
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@ast
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@en
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@nl
P2093
P2860
P1476
Genomic and epigenomic integration identifies a prognostic signature in colon cancer
@en
P2093
Chris Boshoff
Craig M Hooker
James G Herman
Jana Jeschke
Juan M Funes
Kim M Smits
Kornel E Schuebel
Leander Van Neste
Manon van Engeland
P2860
P304
P356
10.1158/1078-0432.CCR-10-2509
P407
P577
2011-01-28T00:00:00Z